Cargando…

Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine

BACKGROUND: One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, which could limit the value of any HIV-1 vaccine candidate currently under test. METHODOLOGY AND FINDINGS: To address the HIV-1 variation, we designed a novel T cell immunogen, designated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Létourneau, Sven, Im, Eung-Jun, Mashishi, Tumelo, Brereton, Choechoe, Bridgeman, Anne, Yang, Hongbing, Dorrell, Lucy, Dong, Tao, Korber, Bette, McMichael, Andrew J., Hanke, Tomáš
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1991584/ https://www.ncbi.nlm.nih.gov/pubmed/17912361 http://dx.doi.org/10.1371/journal.pone.0000984

Ejemplares similares

Correction: Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
por: Létourneau, Sven, et al.
Publicado: (2011)

Protective Efficacy of Serially Up-Ranked Subdominant CD8(+) T Cell Epitopes against Virus Challenges
por: Im, Eung-Jun, et al.
Publicado: (2011)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
por: Ondondo, Beatrice, et al.
Publicado: (2006)

Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction
por: Yang, Hongbing, et al.
Publicado: (2018)

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells
por: Ternette, Nicola, et al.
Publicado: (2015)

Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines
por: Wee, Edmund G., et al.
Publicado: (2021)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
por: Kopycinski, Jakub, et al.
Publicado: (2023)

T cell-based strategies for HIV-1 vaccines
por: Korber, Bette, et al.
Publicado: (2019)

Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopes
por: Ahmed, Tina, et al.
Publicado: (2016)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
por: Borthwick, NJ, et al.
Publicado: (2012)

Characterization of T-Cell Responses to Conserved Regions of the HIV-1 Proteome in BALB/c Mice
por: Ondondo, Beatrice, et al.
Publicado: (2014)

Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors
por: Campion, Suzanne L., et al.
Publicado: (2014)

Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses
por: Hancock, Gemma, et al.
Publicado: (2015)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
por: Ahmed, T, et al.
Publicado: (2012)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens
por: Moyo, Nathifa, et al.
Publicado: (2017)

Graph‐based optimization of epitope coverage for vaccine antigen design
por: Theiler, James, et al.
Publicado: (2017)

Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al
por: Fischer, Will, et al.
Publicado: (2008)

Polyvalent vaccine approaches to combat HIV‐1 diversity
por: Korber, Bette, et al.
Publicado: (2017)

Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth
por: Moyo, Nathifa, et al.
Publicado: (2020)

Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosis
por: Hopkins, Richard, et al.
Publicado: (2011)

Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
por: Theiler, James, et al.
Publicado: (2016)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022)

Immune mobilising T cell receptors redirect polyclonal CD8(+) T cells in chronic HIV infection to form immunological synapses
por: Wallace, Zoë, et al.
Publicado: (2022)

Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection
por: Ritchie, Adam John, et al.
Publicado: (2014)

The HIV-1 protective -35SNP effect in Caucasians is CD8 T cell mediated
por: Corrah, T, et al.
Publicado: (2012)

A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein
por: Sethi, Anurag, et al.
Publicado: (2013)

A single, continuous metric to define tiered serum neutralization potency against HIV
por: Hraber, Peter, et al.
Publicado: (2018)

Development of prophylactic vaccines against HIV-1
por: Schiffner, Torben, et al.
Publicado: (2013)

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects
por: Hancock, Gemma, et al.
Publicado: (2017)

Novel, in-natural-infection subdominant HIV-1 CD8(+) T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines
por: Borthwick, Nicola, et al.
Publicado: (2017)

Combination strategies to durably suppress HIV-1: Soluble T cell receptors
por: Wallace, Zoë, et al.
Publicado: (2022)

Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail
por: Chakraborty, Srirupa, et al.
Publicado: (2020)

HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC
por: Wood, Natasha, et al.
Publicado: (2009)

jpHMM: Improving the reliability of recombination prediction in HIV-1
por: Schultz, Anne-Kathrin, et al.
Publicado: (2009)

jpHMM: improving the reliability of recombination prediction in HIV-1
por: Schultz, Anne-Kathrin, et al.
Publicado: (2010)

Estimating time since infection in early homogeneous HIV-1 samples using a poisson model
por: Giorgi, Elena E, et al.
Publicado: (2010)

Newborn Mice Vaccination with BCG.HIVA(222) + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
por: Saubi, Narcís, et al.
Publicado: (2011)

A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes
por: Schultz, Anne-Kathrin, et al.
Publicado: (2006)

Persistent Malnutrition and Associated Factors among Children under Five Years Attending Primary Health Care Facilities in Limpopo Province, South Africa
por: Modjadji, Perpetua, et al.
Publicado: (2020)

jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1
por: Zhang, Ming, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_as8t5nat44c1kfjp50staomdp4